SMR Stock Slides As UBS Downgrade Triggers Legal Scrutiny
NuScale Power Corporation (NYSE: SMR) shares fell 3.13% on October 13, 2026, closing at $6.49. The decline follows a UBS downgrade from Neutral to Sell, with a price target cut from $10 to $6, citing concerns over delayed deployments, weak customer commitments, and cash burn. Additionally, Pomerantz LLP announced an investigation into potential securities fraud, adding to the uncertainty.
How this was made

The 30-second read
Why it matters
UBS’s downgrade and price-target cut provide a concrete bearish catalyst, while the Pomerantz investigation announcement adds an additional uncertainty layer that can extend the selloff beyond the initial downgrade reaction.
Market read
Traders have a near-term catalyst stack for SMR: downgrade-driven repricing plus legal overhang that can sustain volatility.
What to watch
The article emphasizes cash burn and negative free cash flow through 2028, but does not quantify any new customer contract or financing event that would confirm the worst-case funding path.
Background
SMR is described as effectively pre-revenue with heavy projected negative free cash flow, making it highly sensitive to analyst ratings and legal headlines.
Ticker impact
NuScale Power (SMR) is downgraded by UBS to Sell with a price-target cut, and Pomerantz announces a securities-fraud investigation tied to the selloff.
Likely continued pressure as traders price in execution and funding risk, with additional volatility around legal headlines.
The article attributes the move to a same-day UBS downgrade and a newly announced law-firm investigation, both directly linked to SMR’s selloff and future cash-burn concerns.
Market effects
Adds risk premium to small modular reactor and early-stage nuclear development stories via execution and funding skepticism.
Limited, primarily US small-cap growth sentiment and legal-overhang trading.
Modest, as the catalyst is company-specific (analyst downgrade and US class-action investigation).
Counterpoint
The legal probe is not an allegation of proven wrongdoing, and SMR’s cash position could reduce immediate financing panic if project timelines stabilize.
Key entities
- companyNuScale Power Corporation
Subject of the article, trading as SMR on NYSE, facing a UBS downgrade and a newly announced securities-fraud investigation.
- analyst_firmUBS
Downgraded SMR from Neutral to Sell and cut its price target from $10 to $6.
- law_firmPomerantz LLP
Announced an investigation into NuScale Power for potential securities fraud, tied to the UBS call and SMR selloff.
- analyst_firmRBC Capital
Cut its SMR target from $10 to $7 while keeping a Sector Perform rating.




